| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.0M | — | +719.7% |
| R&D Expense | $9.6M | -3.2% | -35.3% |
| SG&A Expense | $8.2M | -38.1% | -45.8% |
| Operating Income | -$16.8M | +27.4% | +43.7% |
| Net Income | -$19.0M | +11.0% | +72.3% |
| EPS (Basic) | -$0.13 | +13.3% | +72.9% |
| EPS (Diluted) | -$0.13 | +13.3% | +72.9% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.9M | -60.7% | -87.9% |
| Current Assets | $31.7M | -8.3% | -69.7% |
| Total Assets | $34.4M | -7.9% | -67.7% |
| Current Liabilities | $32.9M | +85.4% | -66.8% |
| Total Liabilities | $34.9M | +75.5% | -65.3% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$67.4M | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | -$75K | — | — |
| -$561K |
| -103.2% |
| -109.5% |